The Drug Information Association (DIA) Global Annual Meeting, DIA 2026, is the life sciences industry's largest and longest-running event, building on over 60 years of scientific rigor. This premier gathering in Philadelphia unites over 4,000 professionals from industry, regulatory agencies, academia, and patient advocacy, creating a unique neutral ground to tackle healthcare challenges and accelerate solutions. Attendees can discuss the full spectrum of drug development, from early discovery to post-market surveillance, encompassing regulatory affairs, clinical operations, medical affairs, quality, and safety. The event provides actionable insights into the latest regulatory shifts, clinical trial innovations, and digital health strategies, enabling participants to build strategic clarity and accelerate therapeutic development. It offers unmatched networking opportunities with global peers and regulators, allowing attendees to influence industry standards and evaluate viable innovations. For exhibitors, it’s a powerful platform to showcase products and services to a highly qualified audience of decision-makers, fostering lead generation and brand visibility for advancing global health.
Highlights
5 items
01
Neutral Ground for Global Collaboration
Brings together over 4,000 professionals from industry, regulatory agencies, academia, and patient advocacy from 50+ countries to solve healthcare challenges.
02
Comprehensive Therapeutic Lifecycle Focus
Covers the entire drug development process, from early discovery to post-market surveillance, including regulatory affairs, clinical operations, and safety.
03
"The Exchange" Innovation Hub
Reimagined exhibit hall featuring innovation theaters, content hubs, and interactive demonstrations showcasing cutting-edge advancements in life sciences.
04
LIFT Series for Biotech Startups
Dedicated program offering pitch competitions and networking opportunities for emerging biotech and clintech startups, fostering next-generation innovation.
05
Regulatory Town Halls & Deep Dives
Engage directly with major global health authorities like FDA and MHRA, alongside new Therapeutic Area Pathways for intensive, specialized learning.
The event is scheduled from June 14–18, 2026, in Philadelphia, PA, at the Pennsylvania Convention Center.
It targets over 4,000 life sciences professionals from industry, regulatory agencies, academia, and patient advocacy, involved in drug development and lifecycle management.
Key areas include Therapeutic Lifecycle & Regulatory Affairs, Clinical Development & Innovation, Data, Technology & AI in Life Sciences, and Professional Development.
The "The Exchange" exhibit hall features innovation theaters, content hubs, and interactive demonstrations of cutting-edge advancements.
The meeting is organized by the Drug Information Association (DIA), a global non-profit dedicated to advancing science, policy, and patient outcomes.
